ACS Publications Webinar Series | Advancing bRo5 Chemical Matter to the Clinic and Exploring Novel Kinase Inhibitors
View this ACS Publications webinar to learn about the creation of novel 'bi-steric inhibitors' of mTORC1 and RAS(ON) G12D-Selective inhibitors and their journey into clinical trials, as well as innovative kinase inhibitors developed through the combination of medicinal chemistry and structural biology. Hear from Prof. David Heppner and Dr. Leslie Burnett, winners of the 2025 Philip S. Portoghese Journal of Medicinal Chemistry/ACS Medicinal Chemistry Letters/Division of Medicinal Chemistry Joint Lectureship Awards.